Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$1.58 USD
+0.04 (2.60%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.58 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Earnings News For LXRX
-
Lexicon: Q4 Earnings Snapshot
-
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates
-
Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
-
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
-
Lexicon: Q3 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates
-
Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Lexicon: Q1 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
-
Lexicon: Q4 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Provides Business Update
-
Lexicon: Q3 Earnings Snapshot
-
Lexicon Pharmaceuticals Reports Third Quarter 2022 Financial Results And Provides Business Update
-
Lexicon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates
-
Will Lexicon Pharmaceuticals (LXRX) Report Negative Q2 Earnings? What You Should Know
-
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates
-
Lexicon Pharmaceuticals (LXRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates
-
Will Lexicon Pharmaceuticals (LXRX) Report Negative Q4 Earnings? What You Should Know
-
Lexicon Pharmaceuticals (LXRX) Q3 Earnings Beat Estimates
-
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates
-
Earnings Preview: Lexicon Pharmaceuticals (LXRX) Q2 Earnings Expected to Decline
-
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Tops Revenue Estimates